EnBio Holdings (TSE:6092) Other Current Liabilities: 円581 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6092 EnBio Holdings Inc TSE:6092
59 GF Score
Price 円725.00
GF Value 円802.46
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is EnBio Holdings Other Current Liabilities?

EnBio Holdings TSE:6092 -0.55% 59 Other Current Liabilities is 円581 Mil as of Mar. 2026. GuruFocus rates TSE:6092 with a GF Score™ of 59/100 and a GF Value™ of 円802.46 (Modestly Undervalued). The stock has 4 warning signs investors should review.

EnBio Holdings's other current liabilities for the quarter that ended in Mar. 2026 was 円581 Mil.

EnBio Holdings's quarterly other current liabilities declined from Sep. 2025 (円578 Mil) to Dec. 2025 (円420 Mil) but then increased from Dec. 2025 (円420 Mil) to Mar. 2026 (円581 Mil).

EnBio Holdings's annual other current liabilities declined from Mar. 2024 (円633 Mil) to Mar. 2025 (円421 Mil) but then increased from Mar. 2025 (円421 Mil) to Mar. 2026 (円581 Mil).

EnBio Holdings Other Current Liabilities Related Terms

EnBio Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for EnBio Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EnBio Holdings Other Current Liabilities Chart

EnBio Holdings Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 588.28 607.17 633.18 421.00 581.00

EnBio Holdings Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 421.00 511.00 578.00 420.00 581.00
TSE:6092
59GF Score
EnBio Holdings Inc TSE:6092
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EnBio Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円581 Mil mean?
EnBio Holdings (TSE:6092) has a Other Current Liabilities of 円581 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on EnBio Holdings.
Is EnBio Holdings' Other Current Liabilities too high?
EnBio Holdings' current Other Current Liabilities is 円581 Mil. Overall, EnBio Holdings has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does EnBio Holdings' Other Current Liabilities compare to CTAS and CPRT?
EnBio Holdings' Other Current Liabilities of 円581 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Business Services company?
A good Other Current Liabilities depends on the Business Services industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on EnBio Holdings. EnBio Holdings's current Other Current Liabilities is 円581 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EnBio Holdings stock overvalued right now?
Based on GuruFocus' analysis, EnBio Holdings (TSE:6092) is currently considered Modestly Undervalued. The stock's GF Value™ is 円802.46, compared to a current price of 円725.00 — trading 9.7% below its estimated fair value. The current Other Current Liabilities is 円581 Mil. EnBio Holdings' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For EnBio Holdings (TSE:6092), the current Other Current Liabilities is 円581 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is EnBio Holdings (TSE:6092) Overvalued in 2026?

Based on GuruFocus' analysis, EnBio Holdings stock appears to be undervalued. The current stock price of 円725.00 is trading 9.7% below its estimated GF Value™ of 円802.46. GuruFocus considers EnBio Holdings to be Modestly Undervalued.

Key valuation signals for TSE:6092:

  • Other Current Liabilities: 円581 Mil
  • GF Value™: 円802.46 vs. price of 円725.00 (9.7% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:6092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EnBio Holdings Business Description

Address Tokyo Kandata cho 2-11 O-machi Takaku Building 3F, Chiyoda-ku, Tokyo, JPN
EnBio Holdings Inc is a Japanese company engaged in environmental solution business, tools and chemicals business, and brownfield revitalization business. The environmental business involves investigation, remediation and risk management consulting of contaminated soil and groundwater; Tools and chemicals business involves sales of chemicals used for environmental work such as site investigation and remediation; and brownfield revitalization business which involves purchasing and regeneration of brownfields. The objective of the company is solving soil and groundwater contamination issues.
59GF Score

Get the complete analysis for TSE:6092

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円725.00
Price
円802.46
GF Value